Gangrene
|
disease |
Pathological Conditions, Signs and Symptoms
|
Disease or Syndrome
|
69
|
4
|
0.100 |
None |
|
0 |
|
|
|
Warfarin-induced skin necrosis
|
phenotype |
|
Finding
|
2
|
|
0.100 |
None |
|
0 |
|
|
|
Variable expressivity
|
phenotype |
|
Finding
|
319
|
|
0.100 |
None |
|
0 |
|
|
|
Cerebral Palsy
|
disease |
Nervous System Diseases
|
Disease or Syndrome
|
241
|
69
|
0.100 |
None |
|
0 |
|
|
|
Abnormal pigmentation
|
phenotype |
|
Finding
|
58
|
5
|
0.100 |
None |
|
0 |
|
|
|
Purpura
|
disease |
Pathological Conditions, Signs and Symptoms; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
68
|
1
|
0.100 |
None |
|
0 |
|
|
|
Vitreous Hemorrhage
|
phenotype |
Pathological Conditions, Signs and Symptoms; Eye Diseases
|
Pathologic Function
|
12
|
|
0.100 |
None |
|
0 |
|
|
|
Venous Insufficiency
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
17
|
1
|
0.100 |
None |
|
0 |
|
|
|
Abnormality of the eye
|
phenotype |
|
Anatomical Abnormality
|
56
|
29
|
0.100 |
None |
|
0 |
|
|
|
Abnormality of the cerebral vasculature
|
disease |
|
Anatomical Abnormality
|
18
|
|
0.100 |
None |
|
0 |
|
|
|
Thin skin
|
phenotype |
|
Finding
|
77
|
4
|
0.100 |
None |
|
0 |
|
|
|
Global developmental delay
|
disease |
|
Mental or Behavioral Dysfunction
|
1825
|
553
|
0.100 |
None |
|
0 |
|
|
|
Seizures
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Sign or Symptom
|
2152
|
553
|
0.100 |
None |
|
0 |
|
|
|
Congenital neurologic anomalies
|
group |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases
|
Congenital Abnormality
|
84
|
4
|
0.100 |
None |
|
0 |
|
|
|
Superficial Thrombophlebitis
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
5
|
|
0.100 |
None |
|
0 |
|
|
|
Pulmonary Embolism
|
disease |
Respiratory Tract Diseases; Cardiovascular Diseases
|
Pathologic Function
|
93
|
16
|
0.100 |
None |
|
0 |
|
|
|
Superficial Thrombophlebitis, CTCAE
|
phenotype |
|
Finding
|
3
|
|
0.100 |
None |
|
0 |
|
|
|
WARFARIN SENSITIVITY (disorder)
|
phenotype |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
10
|
8
|
0.010 |
None |
< 0.001 |
1 |
1
|
2011 |
2011 |
Hyperprothrombinemia
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
4
|
|
0.010 |
None |
< 0.001 |
1 |
|
2001 |
2001 |
Extramedullary Hematopoiesis (disorder)
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
52
|
1
|
0.010 |
None |
< 0.001 |
1 |
|
2020 |
2020 |
Peripheral Vascular Diseases
|
group |
Cardiovascular Diseases
|
Disease or Syndrome
|
150
|
18
|
0.010 |
None |
< 0.001 |
1 |
|
1998 |
1998 |
Avitaminosis
|
disease |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
17
|
2
|
0.010 |
None |
< 0.001 |
1 |
|
2001 |
2001 |
Complications of Diabetes Mellitus
|
group |
Endocrine System Diseases
|
Disease or Syndrome
|
240
|
35
|
0.010 |
None |
< 0.001 |
1 |
|
2008 |
2008 |
Vitamin Deficiency
|
group |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
17
|
2
|
0.010 |
None |
< 0.001 |
1 |
|
2001 |
2001 |
Severe hereditary factor VIII deficiency disease
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
37
|
15
|
0.020 |
None |
0.500 |
2 |
|
2009 |
2017 |